Breast cancer in women under 50 years câncer de mama em mulheres a baixo de 50 anos
International Journal of Development Research
Breast cancer in women under 50 years câncer de mama em mulheres a baixo de 50 anos
Received 16th February, 2021; Received in revised form 27th March, 2021; Accepted 04th April, 2021; Published online 22th May, 2021
Copyright © 2021, Nariman de Felicio Bortucan Lenza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective: To identify a breast cancer accident in women under the age of 50 in a city in the interior of Minas Gerais. Methods: Field research, descriptive, with a quantitative approach. For data collection, a semi-structured form was used to interview twenty-five women under 50 years of age diagnosed with breast cancer in the years 2016, 2017 and 2018 and monitored by the Viva Mulher Program. Results: There was a predominance of women aged 41 to 50 years, married and of black race / color, incomplete elementary school and low family income. All interviewees underwent the preventive exam and mammography and 52% of them were overweight. Considering the family history of breast cancer, 72% of women claimed there is no case in their family. Consult the knowledge about breast cancer and its risk factors, 60% do not provide guidance on this factor and in the treatment question, 76% of the women studied received the combined (Surgery, Chemotherapy and Radiotherapy). Conclusion: Breast cancer in young women has a more aggressive pathophysiology when compared to breast tumors in older women and in recent years there has been an increase in its incidence. These women are not covered by the mammographic screening policy proposed by the Ministry of Health. Therefore, it is necessary to implement measures that provide prevention and early detection actions, since it directly influences the chances of remission of the disease and, consequently, the survival of affected women.